ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Delayed Nasdaq			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

21-01-19	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
20-12-22	ACell, Inc. Announces CE Mark Approval	CI

21-01-19	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
20-12-22	ACell, Inc. Announces CE Mark Approval	CI
20-12-15	Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million.	CI
20-07-20	ACell, Inc. has withdrawn its IPO in the amount of $80 million.	CI
20-06-26	ACell, Inc. has filed an IPO in the amount of $86.25 million.	CI
19-09-05	ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana	CI
19-09-04	ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products	CI
19-04-08	ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd	CI
18-10-15	ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix	CI
18-10-08	ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias	CI
18-07-20	ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center	CI
18-05-08	ACell, Inc. Names Nino Pionati as Vice President, International and Business Development	CI
18-04-11	ACell, Inc. Announces Launch of Gentrix® Incisional	CI

Manager	Title	Age	Since
Matthew R. Kunst DFI	Director of Finance/CFO	-	2019-12-31
Patty Meehan ADM	Chief Administrative Officer	-	2001-12-31
Jim Kuras CTO	Chief Tech/Sci/R&D Officer	-	2019-12-31

Director	Title	Age	Since
John J. McDonnell BRD	Director/Board Member	59	-
Martin Pfinsgraff BRD	Director/Board Member	71	2019-06-30
Kyle C. Kerbawy CHM	Chairman	79	2015-07-31

ACell, Inc. Stock

Stocks

ACLL

US00444J1025

Medical Equipment, Supplies & Distribution

Latest news: ACell, Inc.

News in other languages: ACell, Inc.

Managers and Directors: ACell, Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACELL, INC.	-.--%	-.--%	-	-	340M
ABBOTT LABORATORIES	-0.31%	-1.94%	-24.39%	+2.91%	175B
MEDTRONIC PLC	+0.97%	-2.45%	-5.01%	+13.74%	113B
CENCORA, INC.	-1.01%	-4.01%	-1.04%	+66.14%	58.57B
BECTON, DICKINSON AND COMPANY	+0.01%	+1.73%	-0.42%	-30.03%	50.07B
HOYA CORPORATION	-1.02%	+0.58%	+14.49%	+51.88%	49.92B
DEXCOM, INC.	+0.07%	-2.79%	+29.18%	-9.20%	32.69B
MEDLINE INC.	+1.07%	+9.73%	-	-	30.44B
WEST PHARMACEUTICAL SERVICES, INC.	+1.41%	+3.83%	+43.64%	-0.90%	26.07B
SARTORIUS STEDIM BIOTECH	+1.98%	+7.44%	+26.26%	-1.90%	23.55B
Average	+0.34%	+1.38%	+10.34%	+11.58%	56.03B
Weighted average by Cap.	+0.14%	-0.24%	-2.82%	+12.58%

	2018	2019
Net sales	89.22M 78.47M 74.2M 67.3M 126M 8.56B 127M 888M 343M 4.37B 335M 328M 14.04B	101M 88.65M 83.83M 76.03M 143M 9.68B 144M 1B 388M 4.94B 378M 370M 15.87B
Net income	-3.13M -2.75M -2.6M -2.36M -4.44M -301M -4.46M -31.18M -12.04M -153M -11.76M -11.5M -493M	1.45M 1.27M 1.2M 1.09M 2.05M 139M 2.06M 14.43M 5.57M 70.96M 5.44M 5.32M 228M
Net Debt	-	-